Commodore Capital’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-89,775
Closed -$2.85M 36
2023
Q3
$2.85M Buy
+89,775
New +$2.85M 0.33% 28
2021
Q3
Sell
-17,169
Closed -$5.83M 33
2021
Q2
$5.83M Hold
17,169
2.03% 21
2021
Q1
$6.95M Buy
17,169
+10,816
+170% +$4.38M 2.77% 16
2020
Q4
$4.23M Buy
+6,353
New +$4.23M 2.3% 22